Thursday, 3 August 2017

FDA approves AbbVie's hepatitis C drug

(Reuters) - The U.S. Food and Drug Administration on Thursday approved AbbVie Inc's drug to treat certain adults with chronic hepatitis C.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)